These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 2884159)

  • 1. Importance of glucagon in the control of futile cycling as studied in alloxan-diabetic dogs.
    Lickley HL; Kemmer FW; el-Tayeb KM; Vranic M
    Diabetologia; 1987 Mar; 30(3):175-82. PubMed ID: 2884159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. State of metabolic control determines role of epinephrine-glucagon interaction in glucoregulation in diabetes.
    Kemmer FW; Lickley HL; Gray DE; Perez G; Vranic M
    Am J Physiol; 1982 Jun; 242(6):E428-36. PubMed ID: 6124126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Important role of glucagon during exercise in diabetic dogs.
    Wasserman DH; Lickley HL; Vranic M
    J Appl Physiol (1985); 1985 Oct; 59(4):1272-81. PubMed ID: 2865245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of beta-adrenergic mechanisms during exercise in poorly controlled diabetes.
    Wasserman DH; Lickley HL; Vranic M
    J Appl Physiol (1985); 1985 Oct; 59(4):1282-9. PubMed ID: 2865246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucagon suppression improves glucoregulation in moderate but not chronic severe diabetes.
    Lickley HL; Kemmer FW; Doi K; Vranic M
    Am J Physiol; 1983 Oct; 245(4):E424-9. PubMed ID: 6137957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of selective insulin or glucagon deficiency on glucose turnover.
    Lickley HL; Ross GG; Vranic M
    Am J Physiol; 1979 Mar; 236(3):E255-62. PubMed ID: 426056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucagon-like peptide 1 increases insulin sensitivity in depancreatized dogs.
    Sandhu H; Wiesenthal SR; MacDonald PE; McCall RH; Tchipashvili V; Rashid S; Satkunarajah M; Irwin DM; Shi ZQ; Brubaker PL; Wheeler MB; Vranic M; Efendic S; Giacca A
    Diabetes; 1999 May; 48(5):1045-53. PubMed ID: 10331409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extrapancreatic effect of somatostatin infusion to increase glucose clearance.
    Bergman RN; Ader M; Finegood DT; Pacini G
    Am J Physiol; 1984 Sep; 247(3 Pt 1):E370-9. PubMed ID: 6148014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatostatin-induced changes in insulin and glucagon secretion in normal and diabetic dogs.
    Sakurai H; Dobbs R; Unger RH
    J Clin Invest; 1974 Dec; 54(6):1395-402. PubMed ID: 4436439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of glucagon in the pathogenesis of the endogenous hyperglycemia of diabetes mellitus.
    Sakurai H; Dobbs RE; Unger RH
    Metabolism; 1975 Nov; 24(11):1287-97. PubMed ID: 1186499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoration of stable metabolic conditions during islet suppression in dogs.
    Bradley DC; Bergman RN
    Am J Physiol; 1992 Apr; 262(4 Pt 1):E532-8. PubMed ID: 1348903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased hepatic glucagon responses in type 1 (insulin-dependent) diabetes mellitus.
    Orskov L; Alberti KG; Mengel A; Møller N; Pedersen O; Rasmussen O; Seefeldt T; Schmitz O
    Diabetologia; 1991 Jul; 34(7):521-6. PubMed ID: 1916058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of pancreatic hormone responses to the elevation in carbohydrate metabolism with reduced PaO2.
    Zinker BA; Wilson R; Wasserman DH
    Am J Physiol; 1995 Jun; 268(6 Pt 1):E1174-83. PubMed ID: 7611394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of somatostatin to modify effect of glucagon on carbohydrate metabolism in the dog.
    Cherrington AD; Lacy WW; Williams PE; Steiner KE
    Am J Physiol; 1983 Jun; 244(6):E596-602. PubMed ID: 6134474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta endorphin modulation of the glucoregulatory effects of repeated epinephrine infusion in alloxan-diabetic and normal dogs.
    el-Tayeb KM; Vranic M; Brubaker PL; Lickley HL
    Diabetologia; 1987 Sep; 30(9):745-54. PubMed ID: 2962893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions between glucagon and other counterregulatory hormones during normoglycemic and hypoglycemic exercise in dogs.
    Wasserman DH; Lickley HL; Vranic M
    J Clin Invest; 1984 Oct; 74(4):1404-13. PubMed ID: 6148356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracerebroventricular administration of somatostatin octapeptide counteracts the hormonal and metabolic responses to stress in normal and diabetic dogs.
    Miles PD; Yamatani K; Brown MR; Lickley HL; Vranic M
    Metabolism; 1994 Sep; 43(9):1134-43. PubMed ID: 7916119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exercise-induced changes in insulin and glucagon are not required for enhanced hepatic glucose uptake after exercise but influence the fate of glucose within the liver.
    Pencek RR; James FD; Lacy DB; Jabbour K; Williams PE; Fueger PT; Wasserman DH
    Diabetes; 2004 Dec; 53(12):3041-7. PubMed ID: 15561932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of somatostatin on the hepatic extraction of insulin and glucagon in the anesthetized dog.
    Ishida T; Röjdmark S; Bloom G; Chou MC; Field JB
    Endocrinology; 1980 Jan; 106(1):220-30. PubMed ID: 7349954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of insulin deficiency on glucose fluxes and muscle glucose metabolism during exercise.
    Wasserman DH; Mohr T; Kelly P; Lacy DB; Bracy D
    Diabetes; 1992 Oct; 41(10):1229-38. PubMed ID: 1356861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.